Tokyo, Japan

Yasue Wada

This inventor holds 3 USPTO granted patents. Top assignee: Kabushiki Kaisha Yakult Honsha. Active years: 2006-2010.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yasue Wada: Innovator in Cholesterol-Lowering Agents

Introduction

Yasue Wada is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of health and nutrition through her innovative research and development of cholesterol-lowering agents. With a total of 3 patents to her name, Wada is recognized for her dedication to improving public health.

Latest Patents

Wada's latest patents include groundbreaking work on cholesterol-lowering agents and secondary bile acid production inhibitors. Her inventions focus on foods and drinks that contain these agents, specifically highlighting the use of yeast as an active ingredient. This innovative approach aims to provide effective solutions for managing cholesterol levels and promoting overall health.

Career Highlights

Throughout her career, Yasue Wada has been associated with Kabushiki Kaisha Yakult Honsha, a leading company in the health and wellness sector. Her work has not only advanced scientific understanding but has also contributed to the development of practical applications that benefit consumers.

Collaborations

Wada has collaborated with notable colleagues, including Haruji Sawada and Yasuto Yoshida. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yasue Wada's contributions to the field of health through her inventions in cholesterol-lowering agents and secondary bile acid production inhibitors highlight her role as a leading inventor. Her work continues to inspire advancements in nutrition and health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…